Genebase Systems Inc. and Genetrack Biolabs Inc.: DNA Technology Meets Web 2.0 in the Newest Tool for Tracking Your Ancestral Roots
14th Nov 2006, 14:16 GMT
VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) It's gone far beyond dusty old photo albums and hand-drawn family trees: Genebase Systems, in partnership with Genetrack Biolabs Inc., has married DNA with Web 2.0 in the DNA Ancestry Project.
Genebase Systems Inc. and Genetrack Biolabs Inc.: DNA Technology Meets Web 2.0 in the Newest Tool for Tracking Your Ancestral Roots related news:
- Web 2.0 Panel - Web 2.0 Panel — IT Conversations
- Not the Perfect Time Tracking Tool — TopXML Reblogger XML News
- DNAPrint Genomics, Inc.: DNAPrint Genomics Recommends Federal Source for Funding of DNA"Cold Case" Tests — Market Wire - Pharmaceuticals and Biotech
- Mass. Public Schools Adopt Podcasting — Podcasting News
- Vidiom Systems, Inc.: David Housman Joins Vidiom Systems, Inc. as Vice President of Strategic Initiatives — Market Wire - Management Changes
- Web 3.0: What will Mike Arrington do now? — ZDNet Blogs
- The Ancestral Developmental Tool Kit of Land Plants — Int J Plant Sci Latest Articles
- David Housman Joins Vidiom Systems, Inc. as Vice President of Strategic Initiatives — ArriveNet : Press Releases
- Kimball Genetics, Inc. Launches the Warfarin Sensitivity DNA Test for Research — RedOrbit News - Health
- D & E Communications, Inc.: D&E Communications and LAM Systems, Inc. Announce Strategic Teaming Agreement — Market Wire - Telecom
Latest news from Market Wire - Pharmaceuticals and Biotech:
- Qiagen N.V.: QIAGEN Introduces Novel Technology for Customized RNAi Assay Products
- IBEX TECHNOLOGIES INC.: IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- Daiichi Sankyo, Inc.: First Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits
- Daiichi Sankyo, Inc.: WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
- Targeted Genetics Corporation: Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting
- Crucell N.V.: Crucell Announces Third Quarter 2006 Results
- Acambis PLC: Acambis PLC announces Update on US MVA procurement
- SkyePharma PLC: SkyePharma PLC announces Board Appointment
- Base Technologies, Inc.: Base Technologies Award of Air Force Surgeon General Contract Continues Rapid Growth Trend
- Eugene Science, Inc.: Eugene Science Signs Major Distribution Agreement With RexGene Biotech